SpringWorks Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Interest Income on Loans	102,267	108,631	100,868	52,826	36,188	41,756
Total Interest Income	102,267	108,631	100,868	52,826	36,188	41,756
Interest Paid on Deposits	69,624	75,898	65,072	22,449	9,699	14,178
Net Interest Income	32,643	32,733	35,796	30,377	26,489	27,578
Net Interest Income Growth (YoY)	-5.23%	-8.56%	17.84%	14.68%	-3.95%	-9.47%
Income From Trading Activities	21,147	21,116	16,661	10,278	7,744	9,582
Gain (Loss) on Sale of Assets	-5,042	-1,752	-61	-2,678	-	-
Gain (Loss) on Sale of Investments	-1,000	-	-3,000	-	-	653
Other Non-Interest Income	12,749	12,570	10,404	11,965	14,743	12,616
Total Non-Interest Income	27,854	31,934	24,004	19,565	22,487	22,851
Non-Interest Income Growth (YoY)	8.07%	33.04%	22.69%	-12.99%	-1.59%	-10.86%
Revenues Before Loan Losses	60,497	64,667	59,800	49,942	48,976	50,429
Provision for Loan Losses	4,289	3,414	3,447	3,584	-928	8,817
Revenue	56,208	61,253	56,353	46,358	49,904	41,612
Revenue Growth (YoY)	-1.47%	8.70%	21.56%	-7.11%	19.93%	-21.99%
Salaries and Employee Benefits	18,606	17,936	17,738	17,603	18,236	17,614
Occupancy Expenses	1,933	1,845	1,640	2,149	2,261	2,681
Amortization of Goodwill & Intangibles	2,402	2,158	2,112	1,554	1,292	1,470
Selling, General & Administrative	10,827	11,027	10,865	11,248	12,098	11,577
Total Non-Interest Expense	30,831	30,054	29,548	29,831	30,841	31,745
EBT Excluding Unusual Items	25,377	31,199	26,805	16,527	19,063	9,867
Asset Writedown	-	-	-	-	-146	-1,049
Other Unusual Items	1,187	1,187	3,258	678	576	-
Pretax Income	26,563	32,309	30,348	17,058	18,906	8,777
Income Tax Expense	6,788	7,310	5,789	809	4,213	2,678
Earnings From Continuing Operations	19,775	24,999	24,559	16,249	14,693	6,099
Minority Interest in Earnings	-851	-1,020	-1,026	-690	-776	-870
Net Income	18,924	23,979	23,533	15,559	13,917	5,229
Preferred Dividends & Other Adjustments	1,083	1,062	1,101	1,213	1,310	1,331
Net Income to Common	17,841	22,917	22,432	14,346	12,607	3,898
Net Income Growth	-18.21%	1.90%	51.25%	11.80%	166.15%	-29.18%
Basic Shares Outstanding	17,847	18,357	19,478	19,849	20,197	20,169
Diluted Shares Outstanding	17,978	18,485	19,600	19,986	20,302	20,242
Shares Change (YoY)	-5.31%	-5.69%	-1.93%	-1.56%	0.30%	0.04%
EPS (Basic)	1.00	1.25	1.15	0.72	0.62	0.19
EPS (Diluted)	1.00	1.24	1.14	0.72	0.62	0.19
EPS Growth	-13.52%	8.77%	58.33%	16.13%	226.32%	-35.84%
Dividend Per Share	0.660	0.660	0.610	0.320	0.250	0.150
Dividend Growth	8.20%	8.20%	90.63%	28.00%	66.67%	-50.00%
Effective Tax Rate	25.55%	22.63%	19.07%	4.74%	22.28%	30.51%

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q